![Al Robichaud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Al Robichaud
Private Equity Investor chez
Cure Ventures Management LP
Profil
Albert J.
Robichaud is currently a Partner at Cure Ventures Management LP since 2024.
Previously, he was the Chief Scientific Officer at SAGE Therapeutics, Inc. from 2011 to 2023, and held positions as Senior Director & Head-Neuroscience Discovery at Wyeth Research from 2002 to 2010, and VP-Chemistry & Pharmacokinetic Sciences at Lundbeck, Inc. from 2010 to 2011.
He also worked as VP-Chemistry & Pharmacokinetic Sciences at Lundbeck USA Inc. Additionally, he received an undergraduate degree from Rensselaer Polytechnic Institute and a doctorate degree from the University of California, Irvine.
Postes actifs de Al Robichaud
| Sociétés | Poste | Début |
|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Private Equity Investor | 01/01/2024 |
Anciens postes connus de Al Robichaud
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 09/10/2023 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Corporate Officer/Principal | 01/01/2011 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Directeur/Membre du Conseil | 01/01/2010 |
Lundbeck USA Inc. | Corporate Officer/Principal | - |
Formation de Al Robichaud
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Lundbeck USA Inc. | |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
